Ann Arbor, MI, May 16, 2024 – GreenMark Biomedical Inc. announces it will receive up to $200,000 in additional funding to advance its innovative regenerative technology toward products for dental sensitivity treatment and noninvasive mineralization of early-stage dental decay. To date GreenMark raised $8.6 million in equity investment and non-dilutive funding. In the final year […]
Read MoreDr. Nathan Jones, VP of Technology, presented a technical progress update at the 2024 MPWRM Resource Center Annual Stakeholder’s Summit held at the University of Michigan, Ann Arbor, MI. GreenMark CEO Dr. Steven Bloembergen presented in the afternoon investor pitch session. The Center has funded GreenMark Biomedical through its NIH/NIDCR grant program since 2018 on […]
Read More
GreenMark Biomedical recently attended the annual oral health technology innovation convention, Forsyth dentech 2023, hosted by the Forsyth Institute in Cambridge, Massachusetts (see https://forsyth.org/forsyth-dentech/). The institute works in close collaboration with the local biotech hub and the Wyss School of Dentistry at Harvard University. Invited to present in the annual pitch competition as one of several […]
Read More“The result of the present study indicated that the application of LC Rinse vastly improved the sensitivity, specificity, and diagnostic accuracy of visual-tactile caries relative to previous reports. This can be attributed to the fact that the fluorescent particles infiltrated and illuminated only the porous surfaces of the active lesions, and not sound surfaces, inactive […]
Read MoreANN ARBOR, Mich., February 1, 2023 (Newswire.com) – GreenMark Biomedical Inc. “GreenMark” announces its award in the competitive Startup Central Pitch event called The Hub, which the company received on Friday, Jan. 27, 2023 in Boston, Massachusetts. GreenMark‘s CEO Dr. Steven Bloembergen took part in the event, along with six other CEOs of dental startup ventures with a presentation entitled “Redefining […]
Read MoreAugust 24, 2020 – GreenMark Biomedical Inc. announced that the company raised $1.74M in equity financing in the form of convertible notes in anticipation of a Series A financing in 2021
Read MoreSeptember 8, 2021 – GreenMark Biomedical Inc. announced the company has been selected as a 2021 Cellerant Best of Class Technology Award recipient. “During what is once again proving to be a very challenging year for the dental industry, each of these extraordinary companies and their award winning technologies have earned the right to celebrate. I […]
Read More